Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06338878

PAtient Treatment Analysis: Hospital and Wide-ranging Out-of-hospital Care Assessment Yields Insights Into Heart Failure Outcomes

This is a monocentric cohort study conducted in the cardiology department of Nancy hospital. The main purpose of the study is to document the global management strategy of patients hospitalized for heart failure and evaluate the association between patient's care and post-hospitalization outcome.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Nancy

Nancy, France

Location status: Recruiting

Location contact

Laura FILIPPETTI

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Man or women ≥ 18 years
  • Patients hospitalized for cardiac decompensation (ESC 2016 and 2021 criteria)

Exclusion criteria

  • Patient expressing refusal to participate in research
  • Patient who is a minor or under administrative protection
  • Pregnant women
  • Patient with ventricular assistance
  • Patient with congenital heart disease

Treatment and study plan

Primary outcomes

  1. All-cause post-hospitalization mortality

    Time frame: Within 1 year following hospital discharge

    Composite endpoint of all-cause post-hospitalization mortality and rehospitalization for heart failure with outcome 2

  2. Rehospitalization for heart failure

    Time frame: Within 1 year following hospital discharge

    Composite endpoint of all-cause post-hospitalization mortality and rehospitalization for heart failure with outcome 1

Secondary outcomes

  1. Percentage of maximum dose of each cardiotropic treatment indicated in heart failure according to ESC recommendations

    Time frame: Within 1 year following hospital discharge

  2. Influenza and pneumococcal vaccination status

    Time frame: Within 1 year following hospital discharge

  3. Evolution of renal function

    Time frame: During hospitalization for up to 2 months and within 1 year after discharge.

    Note: assessed by creatinine levels and GFR by CKD EPI

  4. All-cause Rehospitalization

    Time frame: Within 1 year following hospital discharge

    Assessed by: Rehospitalization for any cause other than hear failure after discharge.

  5. All-cause mortality

    Time frame: Within 1 year following hospital discharge

Study contacts

Contact information is provided by the study sponsor or research team.

Laura FILIPPETI

CONTACT

[email protected]

0383157322 ext. +33

Nicolas GIRERD

CONTACT

[email protected]

0383157322 ext. +33

Sponsors and collaborators

Lead sponsor

Pr. Nicolas GIRERD

Other

Registry information

Acronym: PATHWAY-HF

Important dates

Study start
2024
Primary completion
2027
Study completion
2029
First posted
Apr 1, 2024
Registry last updated
Apr 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.